Childhood Onset Disorders Top 10
- How can cerebral visual impairment be identified, prevented and treated in children?
- How can treatment for visual pathway damage associated with pre-term birth be developed?
- How do we improve screening and surveillance from the ante-natal period through to childhood to ensure early diagnosis of impaired vision and eye conditions?
- Can the treatment of amblyopia be improved to produce better short and long term outcomes than are possible with current treatments?
- How can cataract be prevented in children?
- What are the causes of coloboma and microphthalmia/anophthalmia and how can they be prevented?
- Can vision be corrected in later life for people with amblyopia?
- How can retinoblastoma be identified, prevented and treated in children?
- Can better treatments for glaucoma in children be developed?
- Can a treatment be developed to improve vision for people with albinism?
The following questions were also discussed and ranked in order of priority at the workshop:
- Is it possible to develop a way of permanently treating coloboma?
- What is the most effective way to assess when amblyopia treatment must be stopped to prevent children from developing adverse conditions such as intractable double vision?
- Is it possible to identify what children with a visual impairment due to coloboma actually see?
- Is the Sbisa bar result a reliable way to determine a person's risk of developing intractable double vision during patching?
- What is the life long prognosis for very premature babies with reduced quality of vision as measured using contrast sensitivity tests?
For full details of all of the questions identified, please see the document below.